Tag: Mount Sinai
-
Cancer Vaccines Enter a New Era of Personalized Immunotherapy
Overview: A Turning Point in Cancer Vaccines For decades, researchers have pursued cancer vaccines as a means to train the immune system to recognize and attack tumors. A comprehensive review from the Icahn School of Medicine at Mount Sinai highlights a pivotal shift: cancer vaccines are moving from generic approaches toward highly personalized immunotherapies. By…
-
Cancer vaccines enter a new era of personalized immunotherapy
A turning point in cancer vaccines Decades of cancer vaccine research are coalescing into a new era of personalized immunotherapy. Led by a comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai, the latest work highlights how advances in genomics, bioinformatics, and immune engineering are enabling vaccines that are tailored to…
-
Cancer Vaccines Enter a New Era: Personalization Accelerates Immunotherapy
Introduction: A Turning Point in Cancer Vaccines Researchers are witnessing a pivotal shift in cancer treatment as vaccines designed to stimulate the immune system against tumors move toward true personalization. A comprehensive review from the Icahn School of Medicine at Mount Sinai synthesizes decades of cancer vaccine research and highlights how advances in tumor sequencing,…
-
Newly Identified Microglia Subtype Offers Protection Against Alzheimer’s Disease
Groundbreaking discovery: a protective microglia subtype In the ongoing effort to understand Alzheimer’s disease, researchers are turning the spotlight onto the brain’s immune sentinels: microglia. A newly identified subtype of these cells appears to play a protective role in the brain, potentially slowing the progression of Alzheimer’s disease. The finding, emerging from collaborations led by…
-
New Microglia Subtype Could Shield Against Alzheimer’s Disease
Groundbreaking Discovery in Brain Immunity In the ongoing battle against Alzheimer’s disease, scientists have uncovered a new subtype of microglia—the brain’s resident immune cells—that appears to shield neural tissue from early damage. The finding, reported by researchers at the Icahn School of Medicine at Mount Sinai, adds a promising piece to the complex puzzle of…
-
A New Microglia Subtype May Shield the Brain from Alzheimer’s
Breaking Discovery: A Protective Microglia Subtype Emerges In the ongoing quest to understand Alzheimer’s disease, scientists have long watched the brain’s resident immune cells, microglia, as both guardians and potential aggressors. A recent study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other institutions, has identified a distinct microglia…